Researchers at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center propose a simpler, safer procedure for treating a certain type of early-stage kidney cancer in older adults.
On May 11 eight nations that adopted the first Arctic Invasive Alien Species strategy and action plan – a section of the Arctic Council’s Fairbanks Declaration – authored by scientists led by the Atkinson Center's David Lodge.
ApoE4, a protein linked to both Alzheimer’s disease, increases the risk of cognitive impairment by reducing the number and responsiveness of blood vessels.
The Atkinson Center for a Sustainable Future is welcoming five new postdoctoral fellows, who will study global food systems, health and energy transitions.
Andrew Rosenblatt ’20, student in the lab of Tobias Doerr, assistant professor of microbiology, is working to make cholera less resistant to treatment by a broad range of antibiotics.
New research suggests genetic variation in the most essential component of the ribosome, ribosomal RNA, may influence how much and which proteins are made.
The Executive M.B.A./M.S. in Healthcare Leadership, which combines a master’s from the Weill Cornell Graduate School of Medical Sciences with an MBA from the Johnson school, graduated its inaugural class in May.
Cornell faculty members are finding answers to questions related to a world on the move with a boost from Cornell’s first Migrations grants, awarded by the “Migrations” Global Grand Challenge.
Reducing antibiotic resistance in animals and developing a lubricating formula in joints for people suffering from arthritis are two of seven projects that received Center for Advanced Technology annual grants.